191 related articles for article (PubMed ID: 9020270)
1. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
Johansson JE; Holmberg L; Johansson S; Bergström R; Adami HO
JAMA; 1997 Feb; 277(6):467-71. PubMed ID: 9020270
[TBL] [Abstract][Full Text] [Related]
2. [Natural disease course in untreated early prostatic carcinoma--the Orebro Study].
Johansson JE
Praxis (Bern 1994); 2001 Sep; 90(36):1507-14. PubMed ID: 11593906
[TBL] [Abstract][Full Text] [Related]
3. Natural history of early, localized prostate cancer.
Johansson JE; Andrén O; Andersson SO; Dickman PW; Holmberg L; Magnuson A; Adami HO
JAMA; 2004 Jun; 291(22):2713-9. PubMed ID: 15187052
[TBL] [Abstract][Full Text] [Related]
4. Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE
Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329
[TBL] [Abstract][Full Text] [Related]
5. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
[TBL] [Abstract][Full Text] [Related]
6. High 10-year survival rate in patients with early, untreated prostatic cancer.
Johansson JE; Adami HO; Andersson SO; Bergström R; Holmberg L; Krusemo UB
JAMA; 1992 Apr 22-29; 267(16):2191-6. PubMed ID: 1556796
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
Holmberg L; Bill-Axelson A; Helgesen F; Salo JO; Folmerz P; Häggman M; Andersson SO; Spångberg A; Busch C; Nordling S; Palmgren J; Adami HO; Johansson JE; Norlén BJ;
N Engl J Med; 2002 Sep; 347(11):781-9. PubMed ID: 12226148
[TBL] [Abstract][Full Text] [Related]
9. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure.
Borre M; Nerstrøm B; Overgaard J
Cancer; 1997 Sep; 80(5):917-28. PubMed ID: 9307192
[TBL] [Abstract][Full Text] [Related]
10. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
[TBL] [Abstract][Full Text] [Related]
11. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
[TBL] [Abstract][Full Text] [Related]
12. 20-year outcomes following conservative management of clinically localized prostate cancer.
Albertsen PC; Hanley JA; Fine J
JAMA; 2005 May; 293(17):2095-101. PubMed ID: 15870412
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term mortality with localized prostate cancer.
Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
[TBL] [Abstract][Full Text] [Related]
14. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
15. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival in a Swedish population-based cohort of men with prostate cancer.
Sandblom G; Dufmats M; Varenhorst E
Urology; 2000 Sep; 56(3):442-7. PubMed ID: 10962312
[TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy versus watchful waiting in early prostate cancer.
Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE;
N Engl J Med; 2005 May; 352(19):1977-84. PubMed ID: 15888698
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen levels as a predictor of lethal prostate cancer.
Fall K; Garmo H; Andrén O; Bill-Axelson A; Adolfsson J; Adami HO; Johansson JE; Holmberg L;
J Natl Cancer Inst; 2007 Apr; 99(7):526-32. PubMed ID: 17405997
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.
Klotz L; Vesprini D; Sethukavalan P; Jethava V; Zhang L; Jain S; Yamamoto T; Mamedov A; Loblaw A
J Clin Oncol; 2015 Jan; 33(3):272-7. PubMed ID: 25512465
[TBL] [Abstract][Full Text] [Related]
20. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]